UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 31

Sortiert nach

Inhaled TLR9 Agonist Renders Lung Tumors Permissive to PD-1 Blockade by Promoting Optimal CD4 + and CD8 + T-cell Interplay

Cancer research (Chicago, Ill.), 2018-09, Vol.78 (17), p.4943-4956

2018

Link zum Volltext

Verfügbarkeit prüfen

S1P Lyase Regulation of Thymic Egress and Oncogenic Inflammatory Signaling

Mediators of inflammation, 2017-01, Vol.2017, p.7685142-19

2017

Link zum Volltext

Verfügbarkeit prüfen

P2Y(2) receptor expression is regulated by C/EBPβ during inflammation in intestinal epithelial cells

The FEBS journal, 2012-08, Vol.279 (16), p.2957

2012

Link zum Volltext

Verfügbarkeit prüfen

Sphingosine-1-phosphate lyase downregulation promotes colon carcinogenesis through STAT3-activated microRNAs

The Journal of clinical investigation, 2014-12, Vol.124 (12), p.5368-5384

2014

Link zum Volltext

Verfügbarkeit prüfen

P2Y2 receptor transcription is increased by NF-kappa B and stimulates cyclooxygenase-2 expression and PGE2 released by intestinal epithelial cells

The Journal of immunology (1950), 2009-10, Vol.183 (7), p.4521-4529

2009

Link zum Volltext

Verfügbarkeit prüfen

S1pping fire: Sphingosine-1-phosphate signaling as an emerging target in inflammatory bowel disease and colitis-associated cancer

Clinical and Experimental Gastroenterology, 2014, Vol.7 (default), p.205-214

2014

Link zum Volltext

Verfügbarkeit prüfen

Intestinal Inflammation Increases the Expression of the P2Y6 Receptor on Epithelial Cells and the Release of CXC Chemokine Ligand 8 by UDP

The Journal of immunology (1950), 2008-02, Vol.180 (4), p.2659-2668

2008

Link zum Volltext

Verfügbarkeit prüfen

CB-011, a BCMA-Specific Allogeneic CAR-T Cell Therapy, Engineered with Next-Generation CRISPR Technology to Express an HLA-E Fusion Transgene to Prevent Immune Cell-Mediated Rejection, for r/r Multiple Myeloma

Transplantation and cellular therapy, 2023-02, Vol.29 (2), p.S392-S393

2023

Link zum Volltext

Verfügbarkeit prüfen

524 - CB-011, a BCMA-Specific Allogeneic CAR-T Cell Therapy, Engineered with Next-Generation CRISPR Technology to Express an HLA-E Fusion Transgene to Prevent Immune Cell-Mediated Rejection, for r/r Multiple Myeloma

Transplantation and cellular therapy, 2023-02, Vol.29 (2), p.S392-S393

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract LB009: A BCMA-specific allogeneic CAR-T cell therapy (CB-011) genome-engineered to express an HLA-E fusion transgene to prevent immune cell rejection

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.LB009-LB009

2022

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3201: CB-012, an allogeneic anti-CLL-1 CAR-T cell therapy engineered with next-generation CRISPR technology to resist both the immunosuppressive tumor microenvironment and immune cell-mediated rejection, for patients with relapsed or refractory acute myeloid leukemia

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.3201-3201

2023

Link zum Volltext

Verfügbarkeit prüfen

Sphingosine-1-Phosphate Signaling and Metabolism Gene Signature in Pediatric Inflammatory Bowel Disease: A Matched-case Control Pilot Study

Inflammatory bowel diseases, 2018-05, Vol.24 (6), p.1321-1334

2018

Link zum Volltext

Verfügbarkeit prüfen

P2Y2 receptor promotes intestinal microtubule stabilization and mucosal re-epithelization in experimental colitis

Journal of cellular physiology, 2013-01, Vol.228 (1), p.99-109

2013

Link zum Volltext

Verfügbarkeit prüfen

P-168 S1P Signaling in Inflammatory Bowel Disease and Colitis-Associated Cancer: Preclinical Studies and Preliminary Findings in Pediatric Inflammatory Bowel Disease Patients

Inflammatory bowel diseases, 2014-12, Vol.20, p.S96

2014

Link zum Volltext

Verfügbarkeit prüfen

P2Y6 receptor contributes to neutrophil recruitment to inflamed intestinal mucosa by increasing CXC chemokine ligand 8 expression in an AP‐1‐dependent manner in epithelial cells

Inflammatory bowel diseases, 2012-08, Vol.18 (8), p.1456-1469

2012

Link zum Volltext

Verfügbarkeit prüfen

Regulation de l'expression du recepteur P2Y2 dans les maladies inflammatoires intestinales par les facteurs de transcription NF-kappaB et C/EBPbeta et son implication dans le processus de reparation de l'epithelium intestinal

Degagne, Emilie

2012

Link zum Volltext
ProQuest

Intestinal Inflammation Increases the Expression of the P2Y sub(6) Receptor on Epithelial Cells and the Release of CXC Chemokine Ligand 8 by UDP

The Journal of immunology (1950), 2008-02, Vol.180 (4), p.2659-2668

2008

Link zum Volltext

Verfügbarkeit prüfen

581 P2Y2 Receptor Promotes Intestinal Epithelial Cell Migration Implying a Role in Epithelial Restitution

Gastroenterology (New York, N.Y. 1943), 2010-05, Vol.138 (5), p.S-82-S-82

2010

Link zum Volltext

Verfügbarkeit prüfen

581 P2Y 2 Receptor Promotes Intestinal Epithelial Cell Migration Implying a Role in Epithelial Restitution

Gastroenterology (New York, N.Y. 1943), 2010, Vol.138 (5), p.S-82-S-82

2010

Link zum Volltext

Verfügbarkeit prüfen

M1841 The P2y6 Receptor Induces the Expression of Cxcl8 Through an ERK-Dependent Activation of C-FOS/C-Jun AP-1 Transcriptional Complex

Gastroenterology (New York, N.Y. 1943), 2010, Vol.138 (5), p.S-430-S-430

2010

Link zum Volltext

Verfügbarkeit prüfen

NFκB-p65 up regulates P2Y2 receptor expression following induction of infla mmationin intestinal epithelial cells (135.35)

The Journal of immunology (1950), 2009-04, Vol.182 (1_Supplement), p.135-135.35

2009

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2259: Tumor abscopal responses induced by the TLR9 agonist, SD-101, are strongly potentiated by a HDAC class I inhibitor, domatinostat

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.2259-2259

2019

Link zum Volltext

Verfügbarkeit prüfen

P2Y 2 Receptor Transcription Is Increased by NF-κB and Stimulates Cyclooxygenase-2 Expression and PGE2 Released by Intestinal Epithelial Cells

The Journal of immunology (1950), 2009-10, Vol.183 (7), p.4521-4529

2009

Link zum Volltext

Verfügbarkeit prüfen

P2Y2 Receptor Transcription Is Increased by NF-κB and Stimulates Cyclooxygenase-2 Expression and PGE2 Released by Intestinal Epithelial Cells1

The Journal of immunology (1950), 2009-09, Vol.183 (7), p.4521-4529

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 31

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(30)
Dissertationen
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(9)
Science & Technology
(9)
Animals
(8)
Humans
(7)
Mice
(5)
Inflammatory Bowel Disease
(4)
Rats
(4)
Caco-2 Cells
(3)
Cell Line
(3)
Colitis
(3)
Epithelial Cells - Metabolism
(3)
Gastroenterology And Hepatology
(3)
Gene Expression
(3)
Genetic Aspects
(3)
Health Aspects
(3)
Immunology
(3)
Inflammation - Metabolism
(3)
Inflammatory Bowel Diseases - Metabolism
(3)
Intestinal Mucosa - Metabolism
(3)
Intestinal Mucosa - Pathology
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Inhaled TLR9 Agonist Renders Lung Tumors Permissive to PD-1 Blockade by Promoting Optimal CD4 + and CD8 + T-cell Interplay

S1P Lyase Regulation of Thymic Egress and Oncogenic Inflammatory Signaling

P2Y(2) receptor expression is regulated by C/EBPβ during inflammation in intestinal epithelial cells

Sphingosine-1-phosphate lyase downregulation promotes colon carcinogenesis through STAT3-activated microRNAs

P2Y2 receptor transcription is increased by NF-kappa B and stimulates cyclooxygenase-2 expression and PGE2 released by intestinal epithelial cells

S1pping fire: Sphingosine-1-phosphate signaling as an emerging target in inflammatory bowel disease and colitis-associated cancer

Intestinal Inflammation Increases the Expression of the P2Y6 Receptor on Epithelial Cells and the Release of CXC Chemokine Ligand 8 by UDP

CB-011, a BCMA-Specific Allogeneic CAR-T Cell Therapy, Engineered with Next-Generation CRISPR Technology to Express an HLA-E Fusion Transgene to Prevent Immune Cell-Mediated Rejection, for r/r Multiple Myeloma

524 - CB-011, a BCMA-Specific Allogeneic CAR-T Cell Therapy, Engineered with Next-Generation CRISPR Technology to Express an HLA-E Fusion Transgene to Prevent Immune Cell-Mediated Rejection, for r/r Multiple Myeloma

Abstract LB009: A BCMA-specific allogeneic CAR-T cell therapy (CB-011) genome-engineered to express an HLA-E fusion transgene to prevent immune cell rejection

Abstract 3201: CB-012, an allogeneic anti-CLL-1 CAR-T cell therapy engineered with next-generation CRISPR technology to resist both the immunosuppressive tumor microenvironment and immune cell-mediated rejection, for patients with relapsed or refractory acute myeloid leukemia

Sphingosine-1-Phosphate Signaling and Metabolism Gene Signature in Pediatric Inflammatory Bowel Disease: A Matched-case Control Pilot Study

P2Y2 receptor promotes intestinal microtubule stabilization and mucosal re-epithelization in experimental colitis

High-Specificity CRISPR-Mediated Genome Engineering in Anti-BCMA Allogeneic CAR T Cells Suppresses Allograft Rejection in Preclinical Models

P-168 S1P Signaling in Inflammatory Bowel Disease and Colitis-Associated Cancer: Preclinical Studies and Preliminary Findings in Pediatric Inflammatory Bowel Disease Patients

P2Y6 receptor contributes to neutrophil recruitment to inflamed intestinal mucosa by increasing CXC chemokine ligand 8 expression in an AP‐1‐dependent manner in epithelial cells

Regulation de l'expression du recepteur P2Y2 dans les maladies inflammatoires intestinales par les facteurs de transcription NF-kappaB et C/EBPbeta et son implication dans le processus de reparation de l'epithelium intestinal

Intestinal Inflammation Increases the Expression of the P2Y sub(6) Receptor on Epithelial Cells and the Release of CXC Chemokine Ligand 8 by UDP

581 P2Y2 Receptor Promotes Intestinal Epithelial Cell Migration Implying a Role in Epithelial Restitution

581 P2Y 2 Receptor Promotes Intestinal Epithelial Cell Migration Implying a Role in Epithelial Restitution

M1841 The P2y6 Receptor Induces the Expression of Cxcl8 Through an ERK-Dependent Activation of C-FOS/C-Jun AP-1 Transcriptional Complex

NFκB-p65 up regulates P2Y2 receptor expression following induction of infla mmationin intestinal epithelial cells (135.35)

Abstract 2259: Tumor abscopal responses induced by the TLR9 agonist, SD-101, are strongly potentiated by a HDAC class I inhibitor, domatinostat

P2Y 2 Receptor Transcription Is Increased by NF-κB and Stimulates Cyclooxygenase-2 Expression and PGE2 Released by Intestinal Epithelial Cells

P2Y2 Receptor Transcription Is Increased by NF-κB and Stimulates Cyclooxygenase-2 Expression and PGE2 Released by Intestinal Epithelial Cells1

Suchergebnisse filtern